FOXM1 and cancer: Likewise, FOXM1 (Forkhead Box M1), predicted as a target of mtr-miR169k, is among the most overexpressed oncoproteins in many types of cancer and therapeutic interventions to suppress its function are of great interest (Halasi et al., 2018).